CD4+ and CD8+ T lymphocytes: Clarification of their pathogenic roles in diabetes in the NOD mouse

Research in Immunology

Volumn 148, Issue 5, 1997, Pages 320-327

  Kay, T W H ^a   Chaplin, H L ^a   Parker, J L ^a   Stephens, L A ^a   Thomas, H E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; EXPERIMENTAL DIABETES MELLITUS; GENETIC RISK; INSULITIS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0030828968     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(97)87241-0     Document Type: Article

References (66)

1. Andre, I., Gonzalez, A., Wang, B., Katz, J., Benoist, C. & Mathis, D. (1996), Checkpoints in the progression of autoimmune disease - lessons from diabetes models. Proc. Natl. Acad. Sci. USA, 93, 2260-2263.
2. Bach, J.F. (1994), Insulin-dependent diabetes mellitus as an autoimmune disease. Endocrine Rev., 15, 516-42.
3. Bendelac, A., Carnaud, C., Boitard, C. & Bach, J.F. (1987), Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells. J. Exp. Med., 166, 823-832.
4. Boitard, C., Yasunami, R., Dardenne, M. & Bach, J.F. (1989), T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med., 169, 1669-80.
5. Bowman, M.A., Leiter, E.H. & Atkinson, M.A. (1994), Prevention of diabetes in the NOD mouse : implications for therapeutic intervention in human disease. Immunol. Today, 15, 115-20.
6. Campbell, I.L., Harrison, L.C., Ashcroft, R.G. & Jack, I. (1988a), Reovirus infection enhances expression of class I MHC proteins on human beta-cell and rat RINm5H cell. Diabetes, 37, 362-5.
7. Campbell, I.L., Kay, T.W., Oxbrow, L. & Harrison, L.C. (1991), Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J. Clin. Invest., 87, 739-42.
8. Campbell, I.L., Oxbrow, L., Koulmanda, M. & Harrison, L.C. (1988b), IFN-gamma induces islet cell MHC antigens and enhances autoimmune, streptozotocin-induced diabetes in the mouse. J. Immunol., 140, 1111-6.
9. Campbell, I.L., Oxbrow, L., West, J. & Harrison, L.C. (1988c), Regulation of MHC protein expression in pancreatic beta-cells by interferon-gamma and tumor necrosis factor-alpha. Mol. Endocrinol., 2, 101-7.
10. Chariten, B., Bacelj, A. & Mandel, T.E. (1988), Administration of silica particles or anti-Lyt2 antibody prevents beta-cell destruction in NOD mice given cyclo-phosphamide. Diabetes, 37, 930-5.
11. Chosich, N. & Harrison, L.C. (1993), Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line. Diabetologia, 36, 716-21.
12. Christianson, S.W., Shultz, L.D. & Leiter, E.H. (1993), Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes, 42, 44-55.
13. Eizirik, D.L., Flodstrom, M., Karlsen, A.E. & Welsh, N. (1996), The harmony of the spheres - inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia, 39, 875-890.
14. Gazda, L.S., Charlton, B. & Lafferty, K.J. (1997), Diabetes results from a late change in the autoimmune response of NOD mice. J. Autoimmun., 10, 261-270.
15. Harada, M. & Makino, S. (1984), Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia, 27, 604-6.
16. Haskins, K. & Wegmann, D. (1996), Diabetogenic T-cell clones. Diabetes, 45, 1299-1305.
17. Healey, D., Ozegbe, P., Arden, S., Chandler, P., Hutton, J. & Cooke, A. (1995), In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J. Clin. Invest., 95, 2979-85.
18. Hultgren, B., Huang, X., Dybdal, N. & Stewart, T.A. (1996), Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes, 45, 812-7.
19. Hutchings, P.R. & Cooke, A. (1990), The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males. J. Autoimmun., 3, 175-85.
20. Imagawa, A., Hanafusa, T., Itoh, N., Miyagawa, J., Nakajima, H., Namba, M., Kuwajima, M., Tamura, S., Kawata, S., Matsuzawa, Y. & Harlan, D.M. (1996), islet-infiltrating T lymphocytes in insulin-dependent diabetic patients express CD80 (B7-1)f and cd86 (B7-2). J. Autoimmun., 9, 391-396.
21. Jansen, A., Homo-Delarche, F., Hooijkaas, H., Leenen, P.J., Dardenne, M. & Drexhage, H.A. (1994), Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of insulitis and beta-cell destruction in NOD mice. Diabetes, 43, 667-75.
22. Kagi, D., Ledermann, B., Burki, K., Zinkernagel, R.M. & Hengartner, H. (1996a), Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol., 14, 207-232.
23. Kagi, D., Odermatt, B., Ohashi, PS., Zinkernagel, R.M. & Hengartner, H. (1996b), Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity. J. Exp. Med., 183, 2143-52.
24. Katz, J., Benoist, C. & Mathis, D. (1993a), Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur. J. Immunol., 23, 3358-3360.
25. Katz, J.D., Benoist, C. & Mathis, D. (1995), T helper cell subsets in insulin-dependent diabetes. Science, 268, 1185-8.
26. Katz, J.D., Wang, B., Haskins, K., Benoist, C. & Mathis, D. (1993b), Following a diabetogenic T cell from genesis through pathogenesis. Cell, 74, 1089-1100.
27. Kay, T., Parker, J.L., Stephens, L.A., Thomas, H.E. & Allison, J. (1996), Rip-beta(2)-microglobulin transgene expression restores insulitis, but not diabetes, in beta(2)-microglobulin(null) nonobese diabetic mice. J. Immunol., 157, 3688-3693.
28. Kay, T.W., Campbell, I.L. & Harrison, L.C. (1991a), Characterization of pancreatic T lymphocytes associated with beta cell destruction in the non-obese diabetic (NOD) mouse. J. Autoimmun., 4, 263-76.
29. Kay, T.W., Campbell, I.L., Oxbrow, L. & Harrison, L.C. (1991b), Overexpression of class I major histocompatibility complex accompanies insulitis in the non-obese diabetic mouse and is prevented by anti-interferon-gamma antibody. Diabetologia, 34, 779-85.
30. Koller, B.H., Marrack, P., Kappler, J.W. & Smithies, O. (1990), Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science, 248, 1227-30.
31. Kurrer, M.O., Pakala, S.V., Hanson, H.L. & Katz, J.D. (1997), Beta cell apoptosis in T cell-mediated autoimmune diabetes. Proc. Natl. Acad. Sci. USA, 94, 213-218.
32. Kurts, C., Heath, W.R., Carbone, F.R., Allison, J., Miller, J. & Kosaka, H. (1996), Constitutive class i-restricted exogenous presentation of self antigens in vivo. J. Exp. Med., 184, 923-930.
33. Larger, E., Becourt, C., Bach, J.F. & Boitard, C. (1995), Pancreatic islet beta cells drive T cell-immune responses in the nonobese diabetic mouse model. J. Exp. Med., 181, 1635-42.
34. Lenschow, D.J., Herold, K.C., Rhee, L., Patel, B., Koons, A., Qin, H.Y., Fuchs, E., Singh, B., Thompson, C.B. & Bluestone, J.A. (1996), CD28/B7 regulation of Th1 and th2 subsets in the development of autoimmune diabetes. Immunity, 5, 285-293.
35. Ljunggren, H.-G., Glas, R., Sandberg, J.K. & Karre, K. (1996), Reactivity and specificity of CD8+ T cells in mice with defects in the MHC class I antigen-presenting pathway. Immunol. Rev., 151, 123-148.
36. Miller, B.J., Appel, M.C., O'Neil, J.J. & J.J. & Wicker, L.S. (1988), Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in non-obese diabetic mice. J. Immunol., 140, 52-58.
37. Miller, J.F. & Heath, W.R. (1993), Self-ignorance in the peripheral T-cell pool. Immunol. Rev., 133, 131-50.
38. Miyazaki, A., Hanafusa, T., Yamada, K., Miyagawa, J., Fujino-Kurihara, H., Nakajima, H., Nonaka, K. & Tarui, S. (1985), Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study. Clin. Exp. Immunol., 60, 622-30.
39. Nagata, M., Santamaria, P., Kawamura, T., Utsugi, T. & Yoon, J.W. (1994), Evidence for the role of CD8+ cytotoxic T cells in the destruction of pancreatic beta-cells in nonobese diabetic mice. J. Immunol., 152, 2042-2050.
40. O'Reilly, L.A., Hutchings, P.R., Crocker, P.R., Simpson, E., Lund, T., Kioussis, D., Takei, F., Baird, J. & Cooke, A. (1991), Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression. Eur. J. Immunol., 21, 1171-80.
41. Ohashi, P.S., Oehen, S., Aichele, P., Pircher, H., Odermatt, B., Herrera, P., Higuchi, Y., Buerki, K., Hengartner, H. & Zinkernagel, R.M. (1993), Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha. J. Immunol., 150, 5185-94.
42. Ohashi, P.S., Oehen, S., Burki, K., Pircher, H., Ohashi, C.T., Odermatt, B., Malissen, B., Zinkernagel, R.M. & Hengartner, H. (1991), Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell, 65, 305-317.
43. Oldstone, M.B., Nerenberg, M., Southern, P., Price, J. & Lewicki, H. (1991), Virus infection triggers insulin-dependent diabretes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell, 65, 319-331.
44. Pozzilli, P., Signore, A., Williams, A.J. & Beales, P.E. (1993), NOD mouse colonies around the world-recent facts and figures. Immunol. Today, 14, 193-6.
45. Rabinovitch, A. (1994), Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Diabetes, 43, 613-621.
46. Rabinovitch, A., Suarez-Pinzon, W.L., Sorensen, O., Bleackley, R.C. & Power, R.F. (1995), IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J. Immunol., 154, 4874-82.
47. Rohane, P.W., Shimada, A., Kim, D.T., Edwards, C.T., Charlton, B., Shultz, L.D. & Fathman, C.G. (1995), Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice. Diabetes, 44, 550-554.
48. Serreze, D.V., Chapman, H.D., Varnum, D.S., Gerling, I., Leiter, E.H. & Shultz, L.D. (1997), Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent. J. Immunol. (in press).
49. Serreze, D.V., Leiter, E.H., Christianson, G.J., Greiner, D. & Roopenian, D.C. (1994), Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes, 43, 505-9.
50. Shehadeh, N.N., LaRosa, F. & Lafferty, K.J. (1993), Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmun., 6, 291-300.
51. Shimada, A., Charlton, B., Rohane, P., Taylor Edwards, C. & Fathman, C.G. (1996), Immune regulation in type 1 diabetes. J. Autoimmun., 9, 263-269.
52. Shimizu, J., Kanagawa, O. & Unanue, E.R. (1993), Presentation of beta-cell antigens to CD4+ and CD8+ T cells of non-obese diabetic mice. J. Immunol., 151, 1723-30.
53. Stephens, L.A. & Kay, T.W.H. (1995), Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse. Int. Immunol., 7, 1885-1895.
54. Sumida, T., Furukawa, M., Sakamoto, A., Namekawa, T., Maeda, T., Zijlstra, M., Iwamoto, I., Koike, T., Yoshida, S., Tomioka, H. & Taniguchi, M. (1994), Prevention of insulitis and diabetes in beta 2-micro-globulin-deficient non-obese diabetic mice. Int. Immunol., 6, 1445-9.
55. Thivolet, C., Bendelac, A., Bedossa, P., Bach, J.F. & Carnaud, C. (1991), CD8+ T cell homing to the pancreas in the nonobese diabetic mouse is CD4+ T cell-dependent. J. Immunol., 146, 85-8.
56. Trembleau, S., Germann, T., Gately, M.K. & Adorini, L. (1995), The role of IL-12 in the induction of organspecific autoimmune diseases. Immunol. Today, 16, 383-6.
57. Verdaguer, J., Yoon, J.W., Anderson, B., Averill, N., Utsugi, T., Park, B.J. & Santamaria, P. (1996), Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8(+) T cells expressing identical endogenous TCR-alpha chains. J. Immunol., 157, 4726-4735.
58. Vonherrath, M.G., Dyrberg, T. & Oldstone, M. (1996), Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice. J. Clin. Invest., 98, 1324-1331.
59. Wang, B., Gonzalez, A., Benoist, C. & Mathis, D. (1996), The role of CD8(+) T cells in the initiation of insulin-dependent diabetes mellitus. Eur. J. Immunol., 26, 1762-1769.
60. Wicker, L.S., Leiter, E.H., Todd, J.A., Renjilian, R.J., Peterson, E., Fischer, P.A., Podolin, P.L., Zijlstra, M., Jaenisch, R. & Peterson, L.B. (1994). Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes, 43, 500-4.
61. Wicker, L.S., Miller, B.J. & Mullen, Y. (1986), Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes, 35, 855-60.
62. Wong, F.S., Visintin, I., Wen, L., Flavell, R.A. & Janeway, C.A. (1996), CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J. Exp. Med., 183, 67-76.
63. Wong, S., Guerder, S., Visintin, I., Reich, E.P., Swenson, K.E., Flavell, R.A. & Janeway, C., Jr. (1995), Expression of the co-stimulator molecule B7-1 in pancreatic beta-cells accelerates diabetes in the NOD mouse. Diabetes, 44, 326-9.
64. Yamada, K., Takanegyotoku, N., Yuan, X., Ichikawa, F., Inada, C. & Nonaka, K. (1996). Mouse islet cell lysis mediated by interleukin-1-induced fas. Diabetologia, 39, 1306-1312.
65. Yasunami, R. & Bach, J.F. (1988), Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur. J. Immunol., 18, 481-4.
66. Zijlstra, M., Bix, M., Simister, N.E., Loring, J.M., Raulet, D.H. & Jaenisch, R. (1990). Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature (Lond.) 344, 742-6.